Wegovy Maintenance Dose UK Guide | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Wegovy Maintenance Dose for Prescription Weight Loss

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £79.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Wegovy Maintenance Dose for Prescription Weight Loss

Understanding the wegovy maintenance dose UK prescription pathway is essential for sustained weight loss success. At Cured Pharmacy, our UK-registered clinical team supports patients through the full dose escalation schedule to the 2.4mg maintenance phase, with transparent pricing from £79.00 and ongoing prescriber guidance.

What Is the Wegovy Maintenance Dose?

The Wegovy maintenance dose is 2.4mg semaglutide administered once weekly via subcutaneous injection [1]. This represents the target therapeutic dose shown in the STEP clinical trial programme to deliver maximum weight loss efficacy whilst maintaining an acceptable side effect profile for most patients.

Patients don't begin at the maintenance dose. The MHRA-approved dose escalation schedule gradually increases from 0.25mg weekly over 16 weeks to reach the 2.4mg maintenance phase [1]. This gradual titration minimises gastrointestinal side effects such as nausea and vomiting, which are most common during initial treatment weeks.

Once you reach the 2.4mg maintenance dose, clinical guidance supports continuing this dose indefinitely, subject to ongoing prescriber review and tolerability assessment [2]. The maintenance phase is not a fixed duration—it's designed for long-term weight management rather than short-term intervention.

Wegovy Dose Escalation Schedule Explained

Your UK prescriber may adjust the escalation timeline if you experience persistent side effects. Remaining at a lower dose for an additional 4 weeks is a common clinical strategy, though this extends the time to reach maintenance. Cured Pharmacy's clinical team monitors your progress through follow-up consultations to optimise your individual pathway.

The Five-Step Titration Protocol

The UK-licensed Wegovy dose escalation follows a structured 16-week schedule: 0.25mg for 4 weeks, 0.5mg for 4 weeks, 1.0mg for 4 weeks, 1.7mg for 4 weeks, then 2.4mg maintenance [1]. Each pen is colour-coded to prevent dosing errors, and your Cured Pharmacy prescription will specify the exact dose for your current treatment phase.

Some patients experience significant weight loss before reaching maintenance dose. However, stopping escalation prematurely may limit overall efficacy. In the STEP-1 trial, patients who reached and maintained the 2.4mg dose achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [3].

How Long Should You Stay on Wegovy Maintenance Dose?

Clinical evidence supports long-term use of the Wegovy maintenance dose for sustained weight management [2]. The STEP trials followed patients for up to 104 weeks, demonstrating that weight loss is maintained whilst continuing treatment but typically rebounds after discontinuation [4].

NICE guidance recognises semaglutide 2.4mg as a long-term treatment option for adults with obesity or overweight plus weight-related comorbidities [5]. There is no predetermined stop date for the maintenance phase—your UK prescriber will review efficacy, tolerability, and ongoing clinical need at regular intervals, typically every 3-6 months.

Weight regain after stopping Wegovy is well-documented in clinical trials. In the STEP-1 withdrawal study, participants who discontinued semaglutide after 68 weeks regained approximately two-thirds of their lost weight within 52 weeks [4]. This underscores that obesity is a chronic condition requiring ongoing management rather than a short-term intervention.

At Cured Pharmacy, our transparent pricing model from £79.00 per prescription supports long-term treatment planning. Your superintendent pharmacist, Tarun Kumar (GPhC 2233073), and our UK prescriber team ensure you receive consistent clinical oversight throughout your maintenance phase.

Treatment Active Ingredient Maintenance Dose Injection Frequency Average Weight Loss Starting Price
Wegovy Semaglutide 2.4mg weekly Once weekly 14.9% at 68 weeks From £89
Mounjaro Tirzepatide 10mg or 15mg weekly Once weekly Up to 22.5% at 72 weeks Prescription required
Saxenda Liraglutide 3.0mg daily Daily injection 8% at 56 weeks Prescription required

Expected Weight Loss Results at Maintenance Dose

Weight loss typically plateaus after 60-68 weeks on the maintenance dose [3]. This plateau represents a new physiological set point rather than treatment failure. Maintaining this reduced weight requires ongoing treatment, as discontinuation consistently leads to weight regain in clinical studies [4].

Clinical Trial Outcomes

The STEP-1 trial enrolled 1,961 adults with obesity or overweight plus comorbidities. At week 68, patients on Wegovy 2.4mg maintenance dose achieved a mean body weight reduction of 14.9%, compared to 2.4% with placebo [3]. Notably, 50.5% of semaglutide-treated participants lost at least 15% of their baseline body weight.

Individual results vary considerably. Factors influencing weight loss magnitude include baseline BMI, adherence to lifestyle modifications, metabolic health, and genetic factors. Your UK prescriber will assess your individual response at 3-4 months to determine whether continuing to maintenance dose is clinically appropriate.

Managing Side Effects During Maintenance Phase

Gastrointestinal side effects—particularly nausea, diarrhoea, and constipation—are most common during dose escalation but typically diminish once patients reach and stabilise on the 2.4mg maintenance dose [1]. Approximately 5-10% of trial participants discontinued treatment due to adverse effects, most commonly during the escalation phase rather than maintenance.

If you experience persistent nausea at the maintenance dose, practical strategies include eating smaller meals, avoiding high-fat foods, and staying well-hydrated. Your Cured Pharmacy prescriber may recommend remaining at 1.7mg if the 2.4mg dose proves intolerable, as many patients still achieve clinically meaningful weight loss at sub-maximal doses.

Rare but serious side effects require immediate medical attention: severe abdominal pain (possible pancreatitis), visual changes, or signs of thyroid tumours. Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain [1]. Your prescriber will assess your personal and family history before prescribing.

All prescription weight loss treatments available through Cured Pharmacy require ongoing clinical monitoring. Our UK-registered team provides follow-up consultations to assess tolerability, efficacy, and any emerging concerns throughout your maintenance phase.

Wegovy Maintenance Dose vs Other Weight Loss Treatments

Your choice of maintenance treatment depends on clinical factors including your weight loss target, injection frequency preference, side effect profile, and cost considerations. Cured Pharmacy offers transparent upfront pricing across all licensed weight loss treatments, with Wegovy available from £79.00 per prescription. Our UK prescribers will discuss the most appropriate option during your free online consultation, which takes under 3 minutes to complete.

Comparing Long-Term Treatment Options

Semaglutide (Wegovy) and tirzepatide (Mounjaro) represent the most effective pharmacological weight loss treatments currently licensed in the UK. Tirzepatide is a dual GIP/GLP-1 receptor agonist that demonstrated superior weight loss in head-to-head trials—approximately 22.5% body weight reduction at the highest maintenance dose compared to 14.9% with semaglutide 2.4mg [6][3].

Liraglutide (Saxenda) is an older GLP-1 receptor agonist requiring daily injections. Its lower efficacy—approximately 8% body weight reduction—makes it less suitable for patients requiring substantial weight loss, though it remains a licensed option for those who cannot tolerate weekly injections [7].

Scientific References

  1. European Medicines Agency. (2021). Wegovy (semaglutide): Summary of Product Characteristics. EMA/CHMP. Retrieved from https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy
  2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
  3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  4. Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725
  5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA875]. Retrieved from https://www.nice.org.uk/guidance/ta875
  6. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  7. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy (semaglutide) is a prescription-only medicine licensed in the UK for weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Individual results may vary. Side effects can occur; refer to the patient information leaflet or consult your prescriber for full safety information.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the Wegovy maintenance dose in the UK?
The Wegovy maintenance dose is 2.4mg semaglutide administered once weekly via subcutaneous injection. This is the target therapeutic dose reached after a 16-week dose escalation schedule.
How long does it take to reach Wegovy maintenance dose?
It takes 16 weeks to reach the 2.4mg Wegovy maintenance dose following the standard UK-licensed escalation schedule: 0.25mg, 0.5mg, 1.0mg, 1.7mg, then 2.4mg, with each dose taken for 4 weeks.
Can I stay on Wegovy maintenance dose long-term?
Yes. Clinical evidence supports long-term use of the Wegovy maintenance dose for sustained weight management, with trials demonstrating safety and efficacy for up to 104 weeks. Your UK prescriber will review your treatment regularly.
What happens if I stop taking Wegovy maintenance dose?
Clinical trials show that most patients regain approximately two-thirds of their lost weight within one year of discontinuing Wegovy. Obesity is a chronic condition requiring ongoing management for sustained results.
How much weight can I lose on Wegovy 2.4mg maintenance dose?
In the STEP-1 trial, patients on Wegovy 2.4mg maintenance dose achieved an average 14.9% body weight reduction over 68 weeks, with 50.5% losing at least 15% of baseline weight. Individual results vary based on adherence and metabolic factors.
Can I reduce my Wegovy dose after reaching maintenance?
Dose reduction is not routinely recommended, as lower doses may provide less weight loss efficacy. However, your UK prescriber may adjust to 1.7mg if you cannot tolerate the 2.4mg maintenance dose whilst still achieving clinical benefit.
Do I need a prescription for Wegovy maintenance dose in the UK?
Yes. Wegovy is a prescription-only medication in the UK. All doses, including the 2.4mg maintenance phase, require clinical assessment by a UK-registered prescriber before dispensing.
How much does Wegovy maintenance dose cost at Cured Pharmacy?
Wegovy is available from £79.00 at Cured Pharmacy, with transparent upfront pricing shown before your free online consultation. Final cost depends on your prescribed dose and treatment duration, as determined by your UK prescriber.